As mentioned, Palantir has declined 32% from its record high in the last seven trading days, but the statistics suggest the ...

Equities researchers at Wedbush boosted their Q4 2024 earnings per share estimates for Playtika in a research report issued on Wednesday, February 26th. Wedbush analyst M. Pachter now forecasts that ...

Research analysts at Wedbush lowered their Q1 2025 EPS estimates for Travere Therapeutics in a report released on Monday, February 24th. Wedbush analyst L. Chico now expects that the company will post ...

Key Takeaways This week’s post-earnings losses brought Nvidia's stock near the January lows that came after a DeepSeek-driven ...

Wedbush analyst Nick Setyan downgraded the shares of Dine Brands Global Inc (NYSE:DIN) from Outperform to Neutral and lowered ...

Praxis Precision Medicines (NASDAQ:PRAX) announced Friday that the company will advance its Essential3 program for its lead asset ulixacaltamide against the neurological disorder essential tremor, ...

Wedbush analyst Daniel Ives maintained a Buy rating on Elastic (ESTC – Research Report) today and set a price target of $135.00. The company’s ...

“Our view is ultimately the bark will be worse than the bite with China tariffs/export controls and this is all a game of ...

Analyst cuts Dine Brands to neutral after the “Really Big Meal Deal” offers value but doesn’t improve same-store sales at ...

The electric vehicle giant’s stock hit a fresh 2025 low on Thursday, now down 25% year to date. Tesla shareholders haven’t ...

Palantir stock has been losing following news of DoD budget cuts. Four US politicians have loaded up on PLTR shares this year ...

Morgan Stanley analysts said Salesforce stock has “significant room for upside” this year despite the company's weaker-than-expected earnings and outlook.